spacer
home > epc > spring 2003 > targeting drugs to the nervous system, fran crawford
PUBLICATIONS
European Pharmaceutical Contractor

Targeting Drugs to the Nervous System, Fran Crawford

The nervous system presents important and difficult problems for drug delivery. The acceptable dose of many drugs is limited by central and peripheral side effects. Many drugs are too large or have physical characteristics which restrict permeability through the lipophilic barrier which protects the central nervous system from foreign molecules entering via the blood. This results in many existing drugs having an inadequate therapeutic index and represents a major challenge in the development of new therapeutics.

One new strategy to address these constraints is to anatomically target drugs to the site of disease in the nervous system through axonal transport, systemic sustained release polymers and mucosal delivery.

Axonal Transport

The peripheral nervous system consists of many neurons, some of which can be up to one metre in length. The nerves in the toe, for example, convey electrical impulses between the periphery and the dorsal root ganglion at the spinal cord for onward transmission via a range of mechanisms into the central nervous system. Within each axon there are complex physiological processes occurring in which endogenous molecules are carried up and down the axon (retrograde and anterograde transport). It has been observed by neurosurgeons that fluorescent markers could be transported up the nerve fibres, imaging both the fibre and the DRG (see Figure 1 ), essentially by 'hitching a ride' on the retrograde system.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

Banner of CRS on Samedan
spacer
By Fran Crawford, Research & Development Director at SynGenix Limited
 
Fran Crawford has extensive experience in managing the development of drugs from early stages through to a product license. Previously, Fran was Chief Scientific Officer of Elan Transdermal Technologies and Managing Director and R&D Director of Ethical Pharmaceuticals.

Fran has over 15 years' experience in managing the preclinical and clinical development of drugs in a small pharmaceutical company. She has an understanding of advanced drug delivery and the regulatory aspects of formulating established drugs around emerging delivery technologies.


spacer
Fran Crawford
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

World Vaccine Congress

10-12 April 2012, Gaylord National Hotel and Convention Center, Washington, US

The 12th annual World Vaccine Congress Washington brings new scientific and business critical debate, discussion and solutions from the true global pioneers shaping vaccine R&D.
More info >>

 
News and Press Releases

More safety in drug packaging

In Germany like in the rest of the world, child safety in drug packaging is an issue that has not been properly solved yet. Today, Faubel, the custom label supplier based in Melsungen, provides a safe and economical solution consisting of an innovative safety label which can be affixed to the back of a tablet blister pack like an ordinary sticker.    
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.